Antenatal diagnosis of sphingolipid and mucopolysaccharide storage diseases.
In 4 years of 24 fetuses at risk for various sphingolipid and mucopolysaccharide storage diseases were examined. Amniocentesis at 16 weeks' gestation was followed in most cases by culture of amniotic fluid cells and measurement in the cells of the activity of the enzyme suspected to be deficient. Six fetuses were affected; five were examined morphologically and biochemically after abortion. Two fetuses had Tay-Sachs disease, two had GM1 gangliosidosis and one had Hurler's syndrome. Although in each affected detus the specific enzyme activity was absent, we found in the placenta 5 to 50% of the normal activity.
D004796:Clinical Enzyme Tests / Q000379:methods; D003951:Diagnostic Errors; D005260:Female; D005696:Galactosidases / Q000378:metabolism; D005865:Gestational Age; D006801:Humans; D008064:Lipidoses / Q000175:diagnosis; D009083:Mucopolysaccharidoses / Q000175:diagnosis*; D008059:Mucopolysaccharidosis I / Q000175:diagnosis; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013106:Sphingolipidoses / Q000175:diagnosis*
D005696:Galactosidases